| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute effect of smoking and of 2 weeks of folate substitution on hemostasis and homocysteine in healthy chronic smokers
|
STRICKER, H.
|
|
2006
|
4 |
11 |
p. 2500-2503
|
artikel
|
| 2 |
Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome
|
NIETO, J. A.
|
|
2006
|
4 |
11 |
p. 2367-2372
|
artikel
|
| 3 |
A head-to-head comparison between the VerifyNow® P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention
|
VAN WERKUM, J. W.
|
|
2006
|
4 |
11 |
p. 2516-2518
|
artikel
|
| 4 |
ANNOUNCEMENTS
|
|
|
2006
|
4 |
11 |
p. 2520
|
artikel
|
| 5 |
Anticoagulant and anti-inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis
|
VAN VEEN, S. Q.
|
|
2006
|
4 |
11 |
p. 2343-2351
|
artikel
|
| 6 |
Anticoagulation therapy after recent bleeding: is it ever safe?
|
WHITE, R. H.
|
|
2006
|
4 |
11 |
p. 2365-2366
|
artikel
|
| 7 |
Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial
|
RUDNICKA, A. R.
|
|
2006
|
4 |
11 |
p. 2405-2410
|
artikel
|
| 8 |
Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy
|
UNDAS, A.
|
|
2006
|
4 |
11 |
p. 2397-2404
|
artikel
|
| 9 |
Between-batch variation of calibrator activity can significantly influence fluorogenic measurement of thrombin generation
|
VAN VEEN, J. J.
|
|
2006
|
4 |
11 |
p. 2514-2516
|
artikel
|
| 10 |
Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration
|
KOJIMA, H.
|
|
2006
|
4 |
11 |
p. 2433-2442
|
artikel
|
| 11 |
Characterization of rat thrombin-activatable fibrinolysis inhibitor (TAFI) – a comparative study assessing the biological equivalence of rat, murine and human TAFI
|
HILLMAYER, K.
|
|
2006
|
4 |
11 |
p. 2470-2477
|
artikel
|
| 12 |
Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression
|
OHKURA, N.
|
|
2006
|
4 |
11 |
p. 2478-2485
|
artikel
|
| 13 |
CORRIGENDUM
|
|
|
2006
|
4 |
11 |
p. 2519
|
artikel
|
| 14 |
Effect of protein C and activated protein C on alveolar fibrin deposition and turnover in a piglet model of septic shock
|
VELDMAN, A.
|
|
2006
|
4 |
11 |
p. 2488-2490
|
artikel
|
| 15 |
Endogenous tissue-type plasminogen activator and cardioembolic brain infarct subtype
|
OLIVOT, J. M.
|
|
2006
|
4 |
11 |
p. 2513-2514
|
artikel
|
| 16 |
Endotoxemia enhances circulating endothelial cells in humans
|
BOOS, C. J.
|
|
2006
|
4 |
11 |
p. 2509-2511
|
artikel
|
| 17 |
Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: the FLEBUS study
|
LECUMBERRI, R.
|
|
2006
|
4 |
11 |
p. 2504-2508
|
artikel
|
| 18 |
Flow-based assays for global assessment of hemostasis. Part 1: biorheologic considerations 1
|
ZWAGINGA, J. J.
|
|
2006
|
4 |
11 |
p. 2486-2487
|
artikel
|
| 19 |
FORTHCOMING ARTICLES IN THE DECEMBER ISSUE
|
|
|
2006
|
4 |
11 |
p. xvi
|
artikel
|
| 20 |
Heparanase induces tissue factor expression in vascular endothelial and cancer cells
|
NADIR, Y.
|
|
2006
|
4 |
11 |
p. 2443-2451
|
artikel
|
| 21 |
Histamine differentially interacts with tumor necrosis factor-α and thrombin in endothelial tissue factor induction: the role of c-Jun NH2-terminal kinase
|
STEFFEL, J.
|
|
2006
|
4 |
11 |
p. 2452-2460
|
artikel
|
| 22 |
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin
|
GILARD, M.
|
|
2006
|
4 |
11 |
p. 2508-2509
|
artikel
|
| 23 |
Interventions to prevent venous thrombosis after air travel: are they necessary? No
|
ROSENDAAL, F. R.
|
|
2006
|
4 |
11 |
p. 2306-2307
|
artikel
|
| 24 |
Interventions to prevent venous thrombosis after air travel, are they necessary? Yes
|
BRENNER, B.
|
|
2006
|
4 |
11 |
p. 2302-2305
|
artikel
|
| 25 |
Is protein C inhibitor antithrombotic and protective in pulmonary hypertension?
|
BEAULIEU, L. M.
|
|
2006
|
4 |
11 |
p. 2327-2330
|
artikel
|
| 26 |
Local administration of recombinant human antithrombin in a mouse model of peritoneal sepsis
|
LOUBELE, S.
|
|
2006
|
4 |
11 |
p. 2340-2342
|
artikel
|
| 27 |
Low protein Z levels and risk of occurrence of deep vein thrombosis
|
SANTACROCE, R.
|
|
2006
|
4 |
11 |
p. 2417-2422
|
artikel
|
| 28 |
Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura
|
LUKEN, B. M.
|
|
2006
|
4 |
11 |
p. 2355-2364
|
artikel
|
| 29 |
Nucleotide receptor signaling in platelets
|
KAHNER, B. N.
|
|
2006
|
4 |
11 |
p. 2317-2326
|
artikel
|
| 30 |
Peptidomimetic inhibitors for activated protein C: implications for hemophilia management
|
BUTENAS, S.
|
|
2006
|
4 |
11 |
p. 2411-2416
|
artikel
|
| 31 |
Platelet activation in subjects carrying factor V Leiden or factor II A20210 mutations
|
GRANDONE, E.
|
|
2006
|
4 |
11 |
p. 2496-2498
|
artikel
|
| 32 |
Platelet nitric oxide synthase is activated by tyrosine dephosphorylation: possible role for SHP-1 phosphatase
|
PATEL, B.
|
|
2006
|
4 |
11 |
p. 2423-2432
|
artikel
|
| 33 |
Postpartum residual venous obstruction of the lower limbs in the matched case–control ‘NOHA first’ study on miscarriage
|
KHAU VAN KIEN, A.
|
|
2006
|
4 |
11 |
p. 2493-2495
|
artikel
|
| 34 |
Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors
|
HEDNER, U.
|
|
2006
|
4 |
11 |
p. 2498-2500
|
artikel
|
| 35 |
Prevalence of immune thrombocytopenia: analyses of administrative data
|
SEGAL, J. B.
|
|
2006
|
4 |
11 |
p. 2377-2383
|
artikel
|
| 36 |
Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study
|
RASMUSSEN, M. S.
|
|
2006
|
4 |
11 |
p. 2384-2390
|
artikel
|
| 37 |
Protective role of protein C inhibitor in monocrotaline-induced pulmonary hypertension
|
NISHII, Y.
|
|
2006
|
4 |
11 |
p. 2331-2339
|
artikel
|
| 38 |
Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction
|
KAIKITA, K.
|
|
2006
|
4 |
11 |
p. 2490-2493
|
artikel
|
| 39 |
The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis
|
YEH, E. T. H.
|
|
2006
|
4 |
11 |
p. 2308-2316
|
artikel
|
| 40 |
The tragic history of AIDS in the hemophilia population, 1982–1984
|
EVATT, B. L.
|
|
2006
|
4 |
11 |
p. 2295-2301
|
artikel
|
| 41 |
The von Willebrand disease prophylaxis network: exploring a treatment concept
|
BERNTORP, E.
|
|
2006
|
4 |
11 |
p. 2511-2512
|
artikel
|
| 42 |
Tissue factor serum levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study
|
KELLER, T. T.
|
|
2006
|
4 |
11 |
p. 2391-2396
|
artikel
|
| 43 |
Unraveling the immunologic response in thrombotic thrombocytopenic purpura
|
KNÖBL, P.
|
|
2006
|
4 |
11 |
p. 2352-2354
|
artikel
|
| 44 |
Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences
|
KUIPERS, S.
|
|
2006
|
4 |
11 |
p. 2373-2376
|
artikel
|
| 45 |
Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome
|
CUADRADO, M. J.
|
|
2006
|
4 |
11 |
p. 2461-2469
|
artikel
|
Tijdschrift beschrijving